|
Index of reports
> Cases with Diarrhoea ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mylotarg (Gemtuzumab Ozogamicin) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mylotarg side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: 74 year old male
Reactions: Diarrhoea, Dehydration, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
CAP Vorinostat UNK
Dosage: 400 mg/daily/po
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
End date: 2011-10-24
Mylotarg
Dosage: 3 mg/m[2]//sc, 3 mg/m[2]/iv
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
Mylotarg
Dosage: 3 mg/m[2]//sc, 3 mg/m[2]/iv
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-25
Vidaza
Dosage: 75 mg/m[2]/daily/sc, 75 mg/m[2]/daily/sc
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-25
Vidaza
Dosage: 75 mg/m[2]/daily/sc, 75 mg/m[2]/daily/sc
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
Possible Mylotarg side effects in 74 year old male
Reported by a physician from United States on 2011-12-28
Patient: 74 year old male, weighing 126.0 kg (277.2 pounds)
Reactions: Diarrhoea, Dehydration, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vidaza
Dosage: 75 mg/m2/day sc or iv on days 1-7
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
Vidaza
Dosage: 75 mg/m2/day sc or iv on days 1-7
Start date: 2011-10-25
Zolinza
Dosage: 400 mg 1x/day on days 1-9
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
Mylotarg
Dosage: 3 mg/m2 over 2 hours on days 4 and 8
Start date: 2011-10-25
Zolinza
Dosage: 400 mg 1x/day on days 1-9
Administration route: Oral
Start date: 2011-10-25
Mylotarg
Dosage: 3 mg/m2 over 2 hours on days 4 and 8
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-19
|
